CPC Biotech Introduces One-Inch Flow Path, Single-Use Sterile Disconnect for Bioprocessing

Rhea-AI Summary

CPC Biotech (NYSE: DOV), part of PSG and Dover, launched the RevolveSD™ Series, a one-inch, single-use sterile disconnect for bioprocess tubing. The product enables sterile disconnection in seconds and in fewer steps than clamp- or sealer-based methods, without special equipment.

RevolveSD uses durable, lightweight PPSU, compatible with harsh chemicals such as those used in antibody drug conjugate manufacturing, and its metal-free construction removes corrosion risk in the flow path. Dual-valve, non-spill technology minimizes residual external fluid, while the one-inch flow path and valve design support smooth, bidirectional, low-turbulence flow for large-scale bioprocessing applications.

Market Context

Set against a backdrop of low reported short positioning and an effective S-3ASR debt shelf, this bi...

Analysis

Set against a backdrop of low reported short positioning and an effective S-3ASR debt shelf, this bioprocessing connector launch adds incremental product breadth. Investors may watch how often similar news has produced only small moves and whether future debt issuance alters that pattern.

Key Figures

Flow path size: 1 inch

1 metrics

Flow path size 1 inch RevolveSD Series one-inch flow path for bioprocess tubing

Historical Context

5 past events · Latest: Jul 08 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 08	product launch	Positive	+0.1%	Launch of Diamond Integrated Fueling Solution for connected tank truck operations.
Jun 30	software launch	Positive	-3.2%	Release of PrimeCenter 5.0 workflow solution for print providers.
Jun 23	software launch	Positive	+0.3%	Introduction of LINE PERFORMANCE OPTIMIZER software for wire and cable production.
Jun 16	earnings date notice	Neutral	-0.8%	Announcement of second quarter 2026 earnings release date and conference call.
Jun 10	software launch	Positive	+2.2%	Launch of CoLOS Version 7 for industrial coding operations.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent product and software launch announcements have produced mostly modest, directionally mixed price reactions for Dover.

Key Terms

polyphenylsulfone (ppsu), antibody drug conjugate, non-spill technology, bioprocess tubing

4 terms

polyphenylsulfone (ppsu) technical

"The RevolveSD Series is made of durable, lightweight polyphenylsulfone (PPSU), which is compatible"

Polyphenylsulfone (PPSU) is a high-performance plastic known for exceptional heat, chemical and impact resistance; it holds shape under repeated sterilization and extreme conditions like a metal that stays lightweight. Investors watch PPSU because it is used in regulated, high-value applications—medical devices, aerospace, and plumbing—where reliability and certification create steady demand, higher product prices, and barriers to new competitors, so changes in PPSU supply, price or adoption can affect manufacturers’ revenue and margins.

antibody drug conjugate medical

"compatible with harsh chemicals used in applications such as antibody drug conjugate manufacturing."

An antibody drug conjugate is a targeted medical treatment that combines a special antibody with a powerful drug, allowing precise delivery of the medicine directly to cancer cells or other harmful cells in the body. For investors, it represents a sophisticated approach to therapy that could improve treatment effectiveness and reduce side effects, potentially leading to significant growth opportunities in the biotech and pharmaceutical sectors.

non-spill technology technical

"The RevolveSD Series features dual-valve, non-spill technology that minimizes residual fluid"

Non-spill technology describes engineering and design features that prevent accidental releases of liquids, chemicals, fuels, or other materials from containers, piping, equipment, or transfer operations. It matters to investors because these features reduce the risk of costly cleanup, regulatory fines, production shutdowns, and reputational damage—similar to a spill-proof lid on a cup that stops messes and saves cleanup time and expense. Such technology can affect operating costs, liability exposure, and regulatory compliance.

bioprocess tubing technical

"product enables sterile disconnection of bioprocess tubing in fewer steps than traditional methods"

Hoses and flexible tubing used to move liquids and gases inside biological manufacturing systems, such as drug or vaccine production lines. Like the plumbing in a house but designed to stay sterile, resist chemicals, and meet regulatory and purity standards, bioprocess tubing affects production speed, contamination risk, and compatibility with equipment—factors that influence manufacturing reliability and supply-chain resilience.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DOWNERS GROVE, Ill., July 15, 2026 /PRNewswire/ -- CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, today announced the launch of the RevolveSD™ Series. The new one-inch, single-use product enables sterile disconnection of bioprocess tubing in fewer steps than traditional methods that rely on clamps or sealers. RevolveSD disconnects allow bioprocessors to complete sterile disconnections in seconds, while also reducing setup time.

"We created RevolveSD connectors to simplify sterile disconnection in biopharmaceutical processes," said Spencer Juola, product manager, CPC Biotech. "Operators can disconnect tubing without special equipment, and as a true one-time disconnect, this product helps prevent unintended reconnection and the associated risks of process sterility breaches."

The RevolveSD Series is made of durable, lightweight polyphenylsulfone (PPSU), which is compatible with harsh chemicals used in applications such as antibody drug conjugate manufacturing. Its metal-free construction also eliminates corrosion risks in the flow path.

The RevolveSD Series features dual-valve, non-spill technology that minimizes residual fluid on the external valve face after disconnection. Its one-inch flow path size and valve design support smooth, bidirectional flow, minimizing turbulence and restriction.

"The RevolveSD Series addresses a real industry need for a high-flow disconnect that is sterile, single-use, and incredibly easy to use, according to early customer feedback," Juola continued. "As the makers of AseptiQuik Series connectors, we have a long history of providing bioprocessors with robust solutions that meet demanding performance requirements. The RevolveSD Series builds on that expertise by bringing new efficiencies to large-scale bioprocessing, streamlining fluid disconnections and reducing tear-down complexities."

For more information about the performance and versatility of the RevolveSD Series, please visit the CPC Biotech website. 

About CPC Biotech:

CPC Biotech is at the forefront of bioprocessing fluid management and flow control, offering a comprehensive portfolio of critical components: connectors, pumps, flow meters and sensors. Our industry-leading products permit biopharma innovators to produce next-generation biologics and therapeutics with optimal integrity, yield, efficiency and scalability. From lab to commercial launch, we enable those who drive breakthroughs in medicines and biologics that transform lives and advance humanity. CPC Biotech is part of Pump Solutions Group (PSG), an operating company within Dover Corporation. To learn more about CPC Biotech, please visit cpc-bio.com.

About PSG:

PSG is the global pump, metering, connector, and dispensing-solution expert, enabling the safe and efficient transfer of critical and valuable fluids that require optimal performance and reliability in applications where it matters most. Additionally, PSG is a leading provider of flow meters designed to reduce waste and downtime while accurately measuring, monitoring and controlling the distribution of fluids. Headquartered in Downers Grove, Illinois, USA, PSG is comprised of several world-class brands, including Abaque, All-Flo, Almatec, Blackmer, CPC Biotech, Cryo-Mach, Ebsray, em-tec, Griswold, Hydro, ipp, Malema, Mouvex, Neptune, Quantex, and Wilden. PSG products are manufactured on three continents – North America, Europe and Asia – in state-of-the-art facilities that practice lean manufacturing and are ISO-certified. PSG is part of the Pumps & Process Solutions segment of Dover Corporation. For additional information on PSG, please visit psgdover.com. PSG: Where Innovation Flows.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 70 years, our team of approximately 24,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com.

CPC Biotech Contact:
Jana Stender
(612) 564-2053
jana.stender@cpc-bio.com

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cpc-biotech-introduces-one-inch-flow-path-single-use-sterile-disconnect-for-bioprocessing-302826616.html

SOURCE Dover

FAQ

What is CPC Biotech's RevolveSD Series announced on July 15, 2026 for DOV?

RevolveSD is a one-inch, single-use sterile disconnect for bioprocess tubing. According to CPC Biotech, it enables sterile disconnection in seconds with fewer steps than clamps or sealers, helping streamline fluid disconnections in large-scale bioprocessing operations.

How does the RevolveSD sterile disconnect improve bioprocessing workflows for Dover (NYSE: DOV)?

RevolveSD allows operators to disconnect tubing quickly without special equipment. According to CPC Biotech, its single-use, true one-time disconnect design reduces setup time, prevents unintended reconnection, and helps lower tear-down complexities in large-scale biopharmaceutical processes.

What materials and compatibility features does CPC Biotech's RevolveSD Series offer?

RevolveSD is made from polyphenylsulfone (PPSU), a durable, lightweight polymer. According to CPC Biotech, PPSU is compatible with harsh chemicals used in applications like antibody drug conjugate manufacturing, and the metal-free construction removes corrosion risks within the flow path.

How does the RevolveSD Series minimize fluid loss and contamination risk in bioprocessing?

RevolveSD uses dual-valve, non-spill technology to reduce residual fluid on the external valve face after disconnection. According to CPC Biotech, this design supports sterile disconnection and helps lower risks associated with process sterility breaches during tubing disconnects.

What flow characteristics does the one-inch RevolveSD disconnect provide for DOV-related bioprocessing systems?

The RevolveSD Series provides a one-inch flow path with a valve design that supports smooth, bidirectional flow. According to CPC Biotech, this configuration minimizes turbulence and flow restriction, supporting high-flow applications in large-scale bioprocessing environments.

How does RevolveSD compare to traditional clamp or sealer methods in sterile disconnection?

RevolveSD enables sterile disconnection in fewer steps and in seconds, compared with clamp or sealer methods. According to CPC Biotech, it reduces setup time and eliminates the need for special equipment during sterile tubing disconnections.